From: Sex differences involved in persistent atrial fibrillation recurrence after radiofrequency ablation
Characteristic | HR (95%CI) | p value |
---|---|---|
Age | 1.006 (0.976–1.037) | 0.695 |
Gender (female vs. male) | 2.099 (1.087–4.053) | 0.027 |
BMI | 1.003 (0.926–1.087) | 0.936 |
AF duration | 1.006 (0.999–1.013) | 0.089 |
Diagnosis and treatment | ||
CAD | 0.719 (0.22–2.351) | 0.585 |
HTN | 1.2 (0.608–2.37) | 0.599 |
DM | 0.689 (0.243–1.952) | 0.483 |
stroke | 1.37 (0.53–3.539) | 0.516 |
Statins | 0.9 (0.41–1.975) | 0.792 |
ACEI/ARB | 1.325 (0.623–2.82) | 0.465 |
CCB | 1.096 (0.499–2.407) | 0.819 |
Beta-block | 0.939 (0.41–2.15) | 0.882 |
EHRA score | ||
1 | 1 (ref) | |
2 | 1.477 (0.574–3.801) | 0.419 |
3 | 1.184 (0.448–3.134) | 0.733 |
CHA2DS2-VASc score ≥ 2 | 1.117 (0.58–2.153) | 0.741 |
HAS-BLED score ≥ 3 | 0.599 (0.082–4.381) | 0.614 |
Non-PV ablation | 1.003 (0.516–1.947) | 0.994 |
LAd, mm (≥ 40 vs. < 40) | 1.966 (0.982–3.937) | 0.056 |
LVEF, % (≥ 50% vs. < 50%) | 1.126 (0.154–8.237) | 0.907 |